W. Rauschning

Check Point (Israel) — Israel

Medicine · Health Sciences

7h-index336citations42works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Photodynamic Therapy Research Studies(8), Cancer Treatment and Pharmacology(5), Cancer therapeutics and mechanisms(5), Head and Neck Cancer Studies(4), Lung Cancer Treatments and Mutations(4)

Publications39 total

Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized)
Ophthalmology and Therapy·2026Open Access
Abstract CT255: Study of PRS-344/S095012 a PD-L1/4-1BB bispecific antibody-Anticalin®-fusion in patients with solid tumors
Cancer Research·2022
Long‐term outcomes following foscan®‐PDT of basal cell carcinomas
Lasers in Surgery and Medicine·2012· 22 cited
Temoporfin‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study
Head & Neck·2010· 113 cited
Efficacy of low-dose mTHPC-PDT for the treatment of basal cell carcinomas
Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE·2009· 1 cited
Temoporfin-mediated photodynamic therapy in advanced, incurable head and neck squamous cell carcinoma: a prospective multicenter trial
2008
Optimization of treatment parameters for Foscan®‐PDT of basal cell carcinomas
Lasers in Surgery and Medicine·2008· 44 cited
Temoporfin-mediated photodynamic therapy in advanced, incurable head and neck squamous cell carcinoma: A prospective multicenter study
Journal of Clinical Oncology·2008
Temoporfin mediated photodynamic therapy in advanced, incurable head and neck cancer: a prospective multicenter study
Journal of Clinical Oncology·2008
Photodynamic therapy (PDT) with mTHPC in the palliation of advanced head and neck cancer in patients who have failed prior therapies and are unsuitable for radiotherapy, surgery or systemic chemotherapy
Journal of Clinical Oncology·2004· 3 cited
Testing of efficacy of photodynamic therapy with a new photosensitizer: a derivative of chlorin e6 (BLC 1010)
Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE·2001
Droloxifen bei postmenopausalen Patientinnen mit metastasiertem Mammakarzinom: Doppelblind randomisierte Phase-ll-Studie
Oncology Research and Treatment·1994· 2 cited
Inhalt, Vol. 17, No. 3, 1994
Oncology Research and Treatment·1994Open Access
Standard-Arbeitsanweisungen (Standard Operating Procedures, SOP) der Phase l/ll-Studiengruppe der Arbeitsgemeinschaft für Internistische Onkologie (AIO) in der Deutschen Krebsgesellschaft
Oncology Research and Treatment·1994· 8 cited
Hinweise für Autoren – Instructions to Authors
Oncology Research and Treatment·1994· 1 citedOpen Access
Briefe an die Herausgeber – Letters to the Editors
Oncology Research and Treatment·1994Open Access
Industrieforum – Industrial Forum
Oncology Research and Treatment·1994Open Access
Preliminary Pages
Oncology Research and Treatment·1994
Inhalt, Vol. 17, Supplement 1, 1994
Oncology Research and Treatment·1994Open Access
Impressum, Vol. 17, No. 3, 1994
Oncology Research and Treatment·1994Open Access
page 1 of 2Next →

Frequent Co-authors

W.E. Berdel(17), Lutz Edler(12), W. Queißer(12), H.-J. Schmoll(12), R. Morant(12), H.J. Senn(12), G.A. Nagel(12), W. Holtkamp(11), C. Manegold(11), R. Becher(10), N. Marschner(9), D. Emrich(8), Michael Kneba(8), Christine Unger(8), S. Kerpel‐Fronius(6), A. Münz(6), E. Späth‐Schwalbe(6), O. Prümmer(6), H.H. Fiebig(6), W.U. Knauf(6)